Showing results (1181-1190 of 1,488) with videos related to
Sort By:
Pageof 149
Urology|July 31, 2021
Functional and Oncological Outcomes of Renal Surgery for Hilar Tumors: Informing the Decisions in Risk-Adapted ManagementRicardo G Alvim, Amy L Tin, Lucas Nogueira, et al.Nature Communications|July 6, 2022
Ligand-induced transmembrane conformational coupling in monomeric EGFRShwetha Srinivasan, Raju Regmi, Xingcheng Lin, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 29, 2017
Systemic Antitumor Immunity by PD-1/PD-L1 Inhibition Is Potentiated by Vascular-Targeted Photodynamic Therapy of Primary TumorsMatthew J O'Shaughnessy, Katie S Murray, Stephen P La Rosa, et al.Nanomedicine : Nanotechnology, Biology, and Medicine|January 27, 2020
Cationic HDL mimetics enhance in vivo delivery of self-replicating mRNAWei He, Angela C Evans, Amy Rasley, et al.The Lancet. Diabetes & Endocrinology|January 31, 2021
Characteristics and outcomes of pregnant women with type 1 or type 2 diabetes: a 5-year national population-based cohort studyHelen R Murphy, Carla Howgate, Jackie O'Keefe, et al.Molecular Cell|January 22, 2008
Structural changes in TAF4b-TFIID correlate with promoter selectivityWei-Li Liu, Robert A Coleman, Patricia Grob, et al.Plos One|June 23, 2022
Identifying locations susceptible to micro-anatomical reentry using a spatial network representation of atrial fibre mapsMax Falkenberg, James A Coleman, Sam Dobson, et al.Cancer|March 18, 2011
Temporal trends and predictors of pelvic lymph node dissection in open or minimally invasive radical prostatectomyAndrew H Feifer, Elena B Elkin, William T Lowrance, et al.International Journal of Radiation Oncology, Biology, Physics|April 18, 2008
Prospective evaluation to establish a dose response for clinical oral mucositis in patients undergoing head-and-neck conformal radiotherapySamir Narayan, Joerg Lehmann, Matthew A Coleman, et al.British Journal of Pharmacology|January 22, 2009
BGC20-1531, a novel, potent and selective prostanoid EP receptor antagonist: a putative new treatment for migraine headacheK A Maubach, R J Davis, D E Clark, et al.Pageof 149